Atlas Trials

EFFECT OF ADDING DAPAGLIFLOZIN TO ALLOGRAFT DYSFUNCTION OF RENAL TRANSPLANTED PATIENTS.

Clinical trial NCT04743453 · COMPLETED

Trial details

NCT number
NCT04743453
Sponsor
University of Sao Paulo General Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Kidney TransplantationDiabetes Mellitus, Type 2Diabetes Complications
Start date
2021-08-17
Primary completion
2024-09-02
Enrollment
211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.